Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Summary

The purpose of this observer-blind study is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' influenza vaccine GSK2584786A in healthy children 6 to 35 months of age.

Timeline

Start

2010-09-30

Primary completion

2011-03-22

Completion

2011-03-22

Outcome

Outcome not reported

Stopped: “The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.”

Drugs

Indications